Literature DB >> 18596568

Risk factors for vaginal vault prolapse surgery in postmenopausal hysterectomized women.

Catharina Forsgren1, Jan Zetterström, Annika López, Daniel Altman.   

Abstract

OBJECTIVE: The purpose of this study was to identify risk factors for surgery of vaginal vault prolapse in hysterectomized postmenopausal women.
DESIGN: We conducted a case-control study. The cases were 117 consecutive postmenopausal hysterectomized women who underwent vaginal vault prolapse surgery at Danderyd Hospital or Karolinska Hospital, Stockholm, between 1996 and 2005. Control participants were 326 age-matched, randomly selected, hysterectomized women with no vaginal vault prolapse surgery, identified from the Swedish Inpatient Register. For participants and controls alike, data on determinants were extracted from patients' records, the Swedish Inpatient Register, and self-report questionnaires. Data were analyzed using nonparametric statistics and logistic regression.
RESULTS: The questionnaire was returned by 90 of 117 participants (77%) and 233 of 326 controls (71%). The mean age at response to the questionnaire was 72.8 (+/- 9.7 SD) and 71.3 (+/- 8.7 SD) years for participants and controls, respectively. In a multivariate analysis, the only predictors at a significant level were age at hysterectomy (odds ratio = 1.04, 95% CI: 1.004-1.08), prolapse or incontinence surgery before hysterectomy (OR = 2.8, 95% CI: 1.0-7.7), and prolapse or incontinence surgery before vaginal vault surgery (OR = 9.1, 95% CI: 3.6-23.4).
CONCLUSIONS: Postmenopausal women with surgically managed pelvic floor disorders are at increased risk of developing vaginal vault prolapse subsequent to a hysterectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18596568     DOI: 10.1097/gme.0b013e31817062a5

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  8 in total

1.  Pelvic organ prolapse (POP) surgery among Danish women hysterectomized for benign conditions: age at hysterectomy, age at subsequent POP operation, and risk of POP after hysterectomy.

Authors:  Rune Lykke; Jan Blaakær; Bent Ottesen; Helga Gimbel
Journal:  Int Urogynecol J       Date:  2014-09-03       Impact factor: 2.894

2.  Pelvic organ prolapse surgery following hysterectomy with benign indication: a national cohort study in Taiwan.

Authors:  Huei-Kai Huang; Dah-Ching Ding
Journal:  Int Urogynecol J       Date:  2018-06-19       Impact factor: 2.894

3.  Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery.

Authors:  Catharina Forsgren; Cecilia Lundholm; Anna L V Johansson; Sven Cnattingius; Jan Zetterström; Daniel Altman
Journal:  Int Urogynecol J       Date:  2011-08-18       Impact factor: 2.894

4.  Age at hysterectomy as a predictor for subsequent pelvic organ prolapse repair.

Authors:  Rune Lykke; Jan Blaakær; Bent Ottesen; Helga Gimbel
Journal:  Int Urogynecol J       Date:  2015-11-13       Impact factor: 2.894

Review 5.  Family history and pelvic organ prolapse: a systematic review and meta-analysis.

Authors:  Parisa Samimi; Sarah H Jones; Ayush Giri
Journal:  Int Urogynecol J       Date:  2020-10-21       Impact factor: 2.894

Review 6.  A systematic review of clinical studies on hereditary factors in pelvic organ prolapse.

Authors:  Sabrina L Lince; Leon C van Kempen; Mark E Vierhout; Kirsten B Kluivers
Journal:  Int Urogynecol J       Date:  2012-03-16       Impact factor: 2.894

7.  A new surgical method of suprapubic and extraperitoneal approach with uterine preservation for pelvic organ prolapse: kurt extraperitoneal ligamentopexy.

Authors:  Sefa Kurt; Mehmet Tunc Canda; Abdullah Tasyurt
Journal:  ISRN Obstet Gynecol       Date:  2013-12-17

8.  Transvaginal Bilateral Sacrospinous Fixation after Second Recurrence of Vaginal Vault Prolapse: Efficacy and Impact on Quality of Life and Sexuality.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Marco Noventa; Pierluigi Giampaolino; Brunella Zizolfi; Salvatore Butticè; Valentina Lucia La Rosa; Giuseppe Gullo; Diego Rossetti
Journal:  Biomed Res Int       Date:  2018-02-28       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.